Stool screening for colorectal cancer: molecular approaches

Area of Science:

• Oncology
• Molecular Diagnostics
• Gastroenterology

Background:

• Colorectal cancer (CRC) screening is crucial for early detection and improved patient outcomes.
• Noninvasive methods, such as stool molecular marker assays, are highly desirable for population-based screening.
• The biologic rationale for stool DNA testing is supported by tumor exfoliation and sensitive detection techniques.

Purpose of the Study:

• To evaluate the potential of molecular markers in stool for noninvasive colorectal cancer screening.
• To explore the challenges and opportunities in developing accurate stool DNA-based tests.
• To discuss the future applications of stool DNA testing in oncology and gastroenterology.

Main Methods:

• Review of current literature on stool DNA testing for colorectal cancer.
• Analysis of molecular marker selection challenges due to cancer heterogeneity.
• Examination of early stool assay results and their limitations.

Main Results:

• No single molecular marker achieves perfect sensitivity for colorectal cancer detection.
• Combinations of markers in early assays show high detection rates for cancer and advanced adenomas in specific groups.
• Large-scale population data for stool DNA testing are currently lacking.

Conclusions:

• Stool molecular marker assays are a promising noninvasive screening approach for colorectal cancer.
• Further marker discovery and technological advancements are needed to improve test performance.
• Potential applications include screening for other cancers and inflammatory bowel disease dysplasia.